Regulation of erythroid iron metabolism by the CLPX unfoldase

CLPX 解折叠酶对红细胞铁代谢的调节

基本信息

  • 批准号:
    10716494
  • 负责人:
  • 金额:
    $ 54.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-21 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT During terminal erythropoiesis, erythroid cells produce significant quantities of heme and heme intermediates which must be coupled to hemoglobin production and iron uptake. Dysregulation of heme synthesis can cause toxic accumulation of heme intermediates and heme deficiency, leading to diseases such as iron overload, anemia and porphyria. We have demonstrated that mitochondrial CLPX, a member of the ubiquitious AAA+ (ATPases associated with various cellular activities) protein unfoldases family, plays a key role in erythroid differentiation by direct regulation of heme synthesis. CLPX functions as a ring-shaped homo-hexamer and is best understood for its function in a proteasome-like enzyme complex with the peptidase CLPP (the CLPXP ATP-dependent protease). In erythroid cells, CLPX is essential for heme synthesis by regulating the terminal steps of porphyrin synthesis and mitochondrial iron metabolism. This finding is conceptually significant as ALA synthesis has until now been understood to be the rate limiting step of porphyrin synthesis. In addition, although the heme synthesis and iron metabolism pathways are coregulated, the mechanisms by which this occurs are poorly understood. This proposal tests the conceptually innovative hypothesis that CLPX coordinates the terminal steps of the heme synthesis pathway with mitochondrial iron metabolism and is a key regulatory node for coupling heme synthesis and iron metabolism to the needs of the erythroid cell. The goal of this proposal is to identify the mechanisms by which CLPX regulates erythoid heme synthesis and erythropoiesis. This will be accomplished by Specific Aim 1, which examines the novel mechanisms by which CLPX regulates the terminal enzymes of the heme synthesis pathway, PPOX and FECH. Specific Aim 2 will identify the mechanisms by which CLPX regulates mitochondrial iron metabolism and the role of iron status in modulating diseases caused by mutations in the CLPX gene. Completion of these specific aims will fundamentally inform our understanding of “housekeeping” proteins like CLPX can have tissue specific functions in erythroid cells. These findings are also of translational significance as they will enable us to determine how to manipulate iron status to treat specific types of iron/heme disorders.
抽象的 在末端红细胞生成期间,红细胞细胞产生大量的血红素和血红素中间体 必须将其与血红蛋白的产生和铁吸收相结合。血红素合成的失调可能导致 血红素中间体和血红素缺乏症的有毒积累,导致铁超载等疾病 贫血和卟啉症。我们已经证明了线粒体Clpx,ubiquiuty AAA+的成员 (与各种细胞活性相关的ATPases)蛋白展开家族,在红斑中起关键作用 通过直接调节血红素合成的分化。 CLPX充当环形均己,是 最好理解其在蛋白酶体样酶复合物与辣椒酶CLPP中的功能(clpxp 依赖ATP的蛋白酶)。在红细胞细胞中,CLPX通过调节末端是血红素合成至关重要的 卟啉合成和线粒体铁代谢的步骤。这一发现在概念上很重要,因为 到目前为止,ALA合成是卟啉合成的速率限制步骤。此外, 尽管血红素的合成和铁代谢途径是核心的,但该机制的机制 发生的情况很差。该提案检验了CLPX的概念创新假设 协调血红素合成途径的末端步骤与线粒体铁代谢,是关键 用于将血红素合成和铁代谢偶联的调节节点满足了红细胞细胞的需求。目标 该建议是确定CLPX调节红斑血红素合成和 红细胞生成。这将通过特定的目标1来完成,该AIM 1研究了新的机制 CLPX调节血红素合成途径,PPOX和FECH的末端酶。具体目标2将 确定CLPX调节线粒体铁代谢的机制以及铁状态在 由CLPX基因突变引起的调节疾病。这些具体目标的完成将 从根本上讲,我们对CLPX(例如CLPX)蛋白质的理解可以特定于组织 在红细胞细胞中起作用。这些发现也具有转化意义,因为它们将使我们能够 确定如何操纵铁状态以治疗特定类型的铁/血红素疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yvette Y Yien其他文献

Yvette Y Yien的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yvette Y Yien', 18)}}的其他基金

Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
  • 批准号:
    10540604
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
  • 批准号:
    10664950
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
  • 批准号:
    10456295
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
  • 批准号:
    10000941
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
  • 批准号:
    10739151
  • 财政年份:
    2019
  • 资助金额:
    $ 54.25万
  • 项目类别:
Mechanism and Function of TMEM14 proteins in vertebrate heme synthesis
TMEM14蛋白在脊椎动物血红素合成中的机制和功能
  • 批准号:
    9751281
  • 财政年份:
    2015
  • 资助金额:
    $ 54.25万
  • 项目类别:
Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
  • 批准号:
    8677578
  • 财政年份:
    2013
  • 资助金额:
    $ 54.25万
  • 项目类别:
Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
  • 批准号:
    8525515
  • 财政年份:
    2013
  • 资助金额:
    $ 54.25万
  • 项目类别:
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
项目 5 弗拉斯卡蒂介导的线粒体代谢,Barry Paw
  • 批准号:
    9924635
  • 财政年份:
  • 资助金额:
    $ 54.25万
  • 项目类别:

相似海外基金

Folding and degradation of membrane proteins
膜蛋白的折叠和降解
  • 批准号:
    9276014
  • 财政年份:
    2016
  • 资助金额:
    $ 54.25万
  • 项目类别:
Folding and degradation of membrane proteins
膜蛋白的折叠和降解
  • 批准号:
    9080665
  • 财政年份:
    2016
  • 资助金额:
    $ 54.25万
  • 项目类别:
Quality Control of Membrane Proteins
膜蛋白的质量控制
  • 批准号:
    8977647
  • 财政年份:
    2015
  • 资助金额:
    $ 54.25万
  • 项目类别:
Quality Control of Membrane Proteins
膜蛋白的质量控制
  • 批准号:
    9147473
  • 财政年份:
    2015
  • 资助金额:
    $ 54.25万
  • 项目类别:
Function and regulation of the proteasome
蛋白酶体的功能和调节
  • 批准号:
    8000778
  • 财政年份:
    2009
  • 资助金额:
    $ 54.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了